Cardiovascular health in early pregnancy and circulating biomarkers of placental health and function

Andrea C. Kozai; Bethany Barone Gibbs; Samuel Parry; Sadiya S. Khan; William Grobman; Lisa D. Levine; Rebecca McNeil; David M. Haas; Jessica L. Pippen; Robert M. Silver; Janet M. Catov

doi:10.1101/2024.08.16.24312132

Abstract

Background Maternal cardiovascular health (CVH) and placental health are related to pregnancy outcomes, yet how early pregnancy CVH affects placentation is not well characterized. The objective of this study was to determine associations between CVH and concentrations of placental proteins.

Methods Participants from the nuMoM2b prospective cohort were included (n=2188). Maternal CVH was defined three ways: (1) composite scores using 6 components measured in the 1^st trimester (four behavioral components of physical activity, diet, sleep duration, and smoking, and the health factors of blood pressure and body mass index); (2) latent classes of the four behavioral components; and (3) individual health behaviors. Linear regression associated composite CVH, latent classes, and individual health behaviors with 1^st and 2^nd trimester circulating markers of placental growth and development (pregnancy-associated plasma protein A, PAPP-A), pro-angiogenic (vascular endothelial growth factor, VEGF; placental growth factor, PlGF), and anti-angiogenic factors (soluble FMS-like tyrosine kinase 1, sFlt-1; soluble endoglin, sEng).

Results and Conclusions More favorable composite CVH was associated with higher PAPP-A (representing better 1^st trimester placental growth and development) and lower VEGF and higher sEng (representing an anti-angiogenic 1^st trimester profile). Higher levels of physical activity were associated with lower 2^nd trimester PAPP-A and higher 1^st trimester VEGF and lower sFlt-1 (pro-angiogenic). In the four groups identified with latent class analysis (Healthy Behaviors, Active with Poor Diet, Inactive with Poor Diet, and Less Healthy Behaviors), first trimester sFlt- 1 was lower in the Healthy Behaviors group compared to Inactive with Poor Diet group. Modifiable aspects of CVH in early pregnancy are related to placental health and function and may be useful targets for intervention.

What is New?

Combinations of modifiable health behaviors in early pregnancy are related to circulating markers of placental development and function.
These associations varied according to trimester of placental biomarker assessment, suggesting that patterns across gestation may be informative.
More physical activity in the 1^st trimester was associated with lower PAPP-A concentrations in the 2^nd trimester without a concurrent increase in the rate of adverse outcomes.

What are the Clinical Implications?

This study suggests that more favorable cardiovascular health in early pregnancy may be related to differences in placental health and function as reflected by higher concentrations of PAPP-A.
One mechanism of the benefits of physical activity in early pregnancy may be through improved angiogenic/anti-angiogenic balance as measured by VEGF and sFlt-1 in the 1^st trimester.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The nuMoM2b project was supported by grant funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): U10 HD063036; U10 HD063072; U10 HD063047; U10 HD063037; U10 HD063041; U10 HD063020; U10 HD063046; U10 HD063048; and U10 HD063053. In addition, support was provided by Clinical and Translational Science Institutes: UL1TR001108 and UL1TR000153. The nuMoM2b Heart Health Study was supported by cooperative agreement funding from the National Heart, Lung, and Blood Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development: U10‐HL119991; U10‐HL119989; U10‐HL120034; U10‐HL119990; U10‐HL120006; U10‐HL119992; U10‐HL120019; U10‐HL119993; U10‐HL120018, and U01HL145358; with supplemental support to NHLBI U10-HL119991 from the Office of Research on Women's Health and the Office of Disease Prevention and to NHLBI U01HL145358 from the Office of Research on Women's Health; and the National Center for Advancing Translational Sciences through UL‐1‐TR000124, UL‐1‐TR000153, UL‐1‐TR000439, and UL‐1‐TR001108; and the Barbra Streisand Women's Cardiovascular Research and Education Program, and the Erika J. Glazer Women's Heart Research Initiative, Cedars-Sinai Medical Center, Los Angeles. The Sedentary Behavior and Cardiovascular Health in Young Women ancillary study is supported by R01HL158652. ACK is supported under NHLBI T32HL083825.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Single IRB Advarra gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes